A detailed history of Advisory Resource Group transactions in Eli Lilly & CO stock. As of the latest transaction made, Advisory Resource Group holds 1,684 shares of LLY stock, worth $1.31 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
1,684
Previous 1,732 2.77%
Holding current value
$1.31 Million
Previous $1.57 Million 4.91%
% of portfolio
0.36%
Previous 0.4%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 20, 2024

SELL
$772.14 - $960.02 $37,062 - $46,080
-48 Reduced 2.77%
1,684 $1.49 Million
Q2 2024

Jul 24, 2024

BUY
$724.87 - $909.04 $37,693 - $47,270
52 Added 3.1%
1,732 $1.57 Million
Q1 2024

May 17, 2024

SELL
$592.2 - $792.28 $29,610 - $39,614
-50 Reduced 2.89%
1,680 $1.31 Million
Q4 2023

Jan 11, 2024

BUY
$525.19 - $619.13 $587,162 - $692,187
1,118 Added 182.68%
1,730 $1.01 Million
Q2 2023

Jul 11, 2023

SELL
$350.74 - $468.98 $1,052 - $1,406
-3 Reduced 0.49%
612 $287,000
Q1 2023

May 15, 2023

BUY
$310.63 - $364.82 $1,242 - $1,459
4 Added 0.65%
615 $211,000
Q4 2022

Jan 27, 2023

BUY
$321.55 - $374.67 $196,467 - $228,923
611 New
611 $0
Q1 2021

May 24, 2021

SELL
$164.32 - $212.72 $387,302 - $501,381
-2,357 Closed
0 $0
Q3 2020

Dec 09, 2020

BUY
$146.22 - $169.13 $344,640 - $398,639
2,357 New
2,357 $349,000
Q3 2019

Nov 19, 2019

SELL
$106.79 - $116.16 $290,682 - $316,187
-2,722 Closed
0 $0
Q1 2019

May 20, 2019

BUY
$111.31 - $131.02 $99,956 - $117,655
898 Added 49.23%
2,722 $316,000
Q4 2018

Feb 12, 2019

BUY
$105.9 - $118.64 $193,161 - $216,399
1,824 New
1,824 $211,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $740B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Advisory Resource Group Portfolio

Follow Advisory Resource Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Resource Group, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Resource Group with notifications on news.